CSL Limited (ASX:CSL)
Australia
· Delayed Price · Currency is AUD 258.67
-0.22 (-0.08%)
Feb 21, 2025, 4:10 PM AEST
CSL Limited Employees
CSL Limited had 32,698 employees as of June 30, 2024. The number of employees increased by 633 or 1.97% compared to the previous year.
Employees
32,698
Change (1Y)
633
Growth (1Y)
1.97%
Revenue / Employee
752.65K AUD
Profits / Employee
135.80K AUD
Market Cap
125.25B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pro Medicus | 69 |
| Cochlear | 5,097 |
| Sonic Healthcare | 42,000 |
| Telix Pharmaceuticals | 234 |
| Ramsay Health Care | 90,000 |
| Ansell | 15,000 |
| Mesoblast | 73 |
| Regis Healthcare | 11,000 |
CSL Limited News
- 2 days ago - CSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE) - PRNewsWire
- 8 days ago - European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine - PRNewsWire
- 8 days ago - European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine - Business Wire
- 9 days ago - European Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) - PRNewsWire
- 11 days ago - Half Year 2025 CSL Ltd Earnings Presentation Transcript - GuruFocus
- 11 days ago - CSL Limited 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 11 days ago - CSL Limited (CSLLY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years - Benzinga